HomeCompareREKRW vs MRK

REKRW vs MRK: Dividend Comparison 2026

REKRW yields 11.44% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $14.2K in total portfolio value· pulled ahead in Year 8
10 years
REKRW
REKRW
● Live price
11.44%
Share price
$17.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.5K
Annual income
$2,337.53
Full REKRW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — REKRW vs MRK

📍 MRK pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodREKRWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, REKRW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
REKRW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REKRW
Annual income on $10K today (after 15% tax)
$971.98/yr
After 10yr DRIP, annual income (after tax)
$1,986.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $6,341.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REKRW + MRK for your $10,000?

REKRW: 50%MRK: 50%
100% MRK50/50100% REKRW
Portfolio after 10yr
$49.7K
Annual income
$6,067.84/yr
Blended yield
12.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

REKRW
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REKRW buys
0
MRK buys
0
No recent congressional trades found for REKRW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricREKRWMRK
Forward yield11.44%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$42.5K$56.8K
Annual income after 10y$2,337.53$9,798.13
Total dividends collected$17.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: REKRW vs MRK ($10,000, DRIP)

YearREKRW PortfolioREKRW Income/yrMRK PortfolioMRK Income/yrGap
1$11,844$1,143.51$11,206$366.19+$638.00REKRW
2$13,938$1,265.72$12,650$502.35+$1.3KREKRW
3$16,306$1,392.14$14,407$694.19+$1.9KREKRW
4$18,970$1,522.08$16,585$967.82+$2.4KREKRW
5$21,952$1,654.87$19,342$1,363.89+$2.6KREKRW
6$25,279$1,789.79$22,913$1,947.19+$2.4KREKRW
7$28,974$1,926.17$27,662$2,823.89+$1.3KREKRW
8← crossover$33,066$2,063.33$34,159$4,173.35$1.1KMRK
9$37,581$2,200.65$43,337$6,308.80$5.8KMRK
10$42,550$2,337.53$56,776$9,798.13$14.2KMRK

REKRW vs MRK: Complete Analysis 2026

REKRWStock

Rekor Systems, Inc., a technology company, provides infrastructure solutions for transportation, public safety, and urban mobility markets in the United States and internationally. The company’s platforms include Rekor One, an AI-powered roadway intelligence platform; Rekor Command, a comprehensive cross-agency platform that offers various applications for traffic management centers, freeway service patrol, first responders, and maintenance crews; Rekor Discover, a platform that ingests data from its hardware and automates comprehensive analytics and actionable insights about the movement of objects across the roadway; and Rekor Scout platform, which automates previously manual processes with collaborative solutions that keep all stakeholders apprised of developing situations and accelerate reaction times to incidents and offenders. It also offers Rekor AutoNotice, a cloud-based financial management application that delivers a turnkey information and citation management solution for cities, states, and municipalities for primary and secondary offenses; and Rekor CarCheck, which allows its AI based vehicle and license plate recognition technology to be accessed for a range of commercial applications. In addition, the company offers Rekor Edge Max System, a fixed traffic data collection system that captures and transforms roadway data into holistic traffic insights; Rekor Edge Pro, a vehicle recognition solution that is used on a standalone basis or integrated into a network; and Rekor Edge Flex, a portable data collection system. Further, it provides traffic services, including traditional traffic studies, which delivers data and insights for planning and management of roadway infrastructure and commercial initiatives; innovative AI-driven traffic studies, for traffic management; and extensive traffic engineering services. The company was incorporated in 2017 and is headquartered in Columbia, Maryland.

Full REKRW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this REKRW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REKRW vs SCHDREKRW vs JEPIREKRW vs OREKRW vs KOREKRW vs MAINREKRW vs JNJREKRW vs ABBVREKRW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.